Wie hoch ist der Preis für Aroa Biosurgery Limited (ARX)

Preis für Aroa Biosurgery Limited (ARX) ist $0.39848591

Wie hoch ist die Marktkapitalisierung für Aroa Biosurgery Limited (ARX)

Marktkapitalisierung für Aroa Biosurgery Limited (ARX) ist $137.67M

Aroa Biosurgery Limited (ARX) Dividendenrendite

Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.

Jahr	Dividendenrendite	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Dividendenrendite

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Dividendenrendite	Land
Abbott Laboratories ABT.US	2.23%	US
Stryker Corporation SYK.US	1.03%	US
Medtronic plc MDT.US	3.69%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Siemens Healthineers AG SHL.DE	0.00%	DE

Unternehmen

Dividendenrendite

Land